Termination of Clinical Trials. Either Party may terminate this Agreement or any applicable Statement of Work if such Party receives notice that the production of Product hereunder or the clinical trials for which Product is being produced hereunder have been or will be suspended or terminated by the FDA (or other regulatory authority) due to failure of the Product by providing written notice of termination not less than [*] in advance of the date of termination. For the avoidance of doubt, in the event of termination under this Section 14.3.2, CLIENT shall remain liable for all fees (including monthly fees) owed pursuant to each outstanding Statement of Work during such two-month period.
Appears in 2 contracts
Samples: Manufacturing Services Agreement (Gamida Cell Ltd.), Manufacturing Services Agreement (Gamida Cell Ltd.)
Termination of Clinical Trials. Either Party may terminate this Agreement or any applicable Statement of Work if such Party receives notice that the production of Product hereunder or the clinical trials for which Product is being produced hereunder have been or will be suspended or terminated by the FDA (or other regulatory authority) due to failure of the Product by providing written notice of termination not less than [*] 2 months in advance of the date of termination. For the avoidance of doubt, in the event of termination by CLIENT under this Section 14.3.2, CLIENT shall shall, at minimum, remain liable for all fees (including monthly fees) owed pursuant to each any outstanding Statement of Work during such two-month period.
Appears in 2 contracts
Samples: Know How License and Stock Purchase Agreement (Regenicin, Inc.), Know How License and Stock Purchase Agreement (Regenicin, Inc.)
Termination of Clinical Trials. Either Party may terminate this Agreement or any applicable Statement of Work if such Party receives notice that the production of Product hereunder or the clinical trials for which Product is being produced hereunder have been or will be suspended or terminated by the FDA (or other regulatory authority) due to failure of the Product by providing written notice of termination not less than [*] 2 months in advance of the date of termination. For the avoidance of doubt, in the event of termination by CLIENT under this Section 14.3.214.3, CLIENT shall shall, at minimum, remain liable for all fees (including monthly fees) owed pursuant to each any outstanding Statement of Work during such two-month period.
Appears in 1 contract
Samples: Manufacturing Services Agreement (Genesis Biopharma, Inc)
Termination of Clinical Trials. Either Party may terminate this Agreement or any applicable Statement of Work if such Party receives notice that the production of Product hereunder or the clinical trials for which Product is being produced hereunder have been or will be suspended or terminated by the FDA (or other regulatory authority) EMA due to failure of the Product by providing written notice of termination not less than [*] 2 months in advance of the date of termination. For the avoidance of doubt, in the event of termination by CLIENT under this Section 14.3.213.3.3, CLIENT shall remain liable for all fees (including monthly fees) owed pursuant to each outstanding Statement of Work during such two-month period.remain
Appears in 1 contract
